INTRODUCTION
Because, after the face, hands are the most visible part of the human body, requests for rejuvenation with nonsurgical aesthetic procedures are increasing.1 However, the anatomic complexity of the hand, the major thinness of its skin, and the extreme mobility of its underlying tissues involve the use of specific implants that respect hand dynamics.2-4 Specific injection methods have been developed to restore hand volume and hide veins and tendons that become visible during aging.4,5 Several dermal fillers commonly used for face rejuvenation have been tested for hand treatment, including hyaluronic acid-based dermal fillers (HA-fillers). The latter are generally well-tolerated and long-lasting and enable reversible interventions thanks to hyaluronidase injections.4-6 Just like for facial rejuvenation, the choice of the right HA-filler depends on the desired correction, the injection depth, and local specificities of the treated area (ie, skin thickness and soft tissues mobility).7,8
We present a case series that demonstrated the immediate aesthetic effect, durability, and safety of HA-filler retrograde sub-dermal injection in the dorsum of the hand for hand rejuvenation.
We present a case series that demonstrated the immediate aesthetic effect, durability, and safety of HA-filler retrograde sub-dermal injection in the dorsum of the hand for hand rejuvenation.
MATERIALS AND METHODS
Between August 2016 and December 2017, one physician (PM) carried out HA-filler injections among 5 subjects at his private office.
Subjects, 4 Caucasian and 1 Spanish-Native American women, with Fitzpatrick phenotypes II–V and moderate to advanced photoaging as assessed using the Glogau Wrinkle Scale, were aged between 56 and 67 years (Table 1). None had skin lesions on the hands or allergy to HA-filler or anesthetic agent (lidocaine). In compliance with the Helsinki declaration, all were informed about the product and injection procedure, and signed a consent form before the injection.
The HA-filler, Teosyal RHA® 3 (Teoxane SA, Geneva, Switzerland), is a viscoelastic, sterile, non-pyrogenic, clear, colorless, and biodegradable gel containing crosslinked sodium HA from
Subjects, 4 Caucasian and 1 Spanish-Native American women, with Fitzpatrick phenotypes II–V and moderate to advanced photoaging as assessed using the Glogau Wrinkle Scale, were aged between 56 and 67 years (Table 1). None had skin lesions on the hands or allergy to HA-filler or anesthetic agent (lidocaine). In compliance with the Helsinki declaration, all were informed about the product and injection procedure, and signed a consent form before the injection.
The HA-filler, Teosyal RHA® 3 (Teoxane SA, Geneva, Switzerland), is a viscoelastic, sterile, non-pyrogenic, clear, colorless, and biodegradable gel containing crosslinked sodium HA from